9th Annual European Antibody Congress, November 11–13, 2013, Geneva, Switzerland
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
9th Annual European Antibody Congress, November 11–13, 2013, Geneva, Switzerland
Authors
Keywords
-
Journal
mAbs
Volume 6, Issue 2, Pages 309-326
Publisher
Informa UK Limited
Online
2014-01-21
DOI
10.4161/mabs.27903
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Curative Outcome of Radioimmunotherapy in a Mouse Breast Cancer Model Relies on mTOR Signaling
- (2014) Inge Verbrugge et al. RADIATION RESEARCH
- Off-rate screening for selection of high-affinity anti-drug antibodies
- (2013) Francisco Ylera et al. ANALYTICAL BIOCHEMISTRY
- Mass Spectrometric Characterization of Transglutaminase Based Site-Specific Antibody–Drug Conjugates
- (2013) Santiago E. Farias et al. BIOCONJUGATE CHEMISTRY
- Sustained peripheral depletion of amyloid-β with a novel form of neprilysin does not affect central levels of amyloid-β
- (2013) Simon J. Henderson et al. BRAIN
- A Human ICAM-1 Antibody Isolated by a Function-First Approach Has Potent Macrophage-Dependent Antimyeloma Activity In Vivo
- (2013) Niina Veitonmäki et al. CANCER CELL
- Knowledge-Based Design of a Biosensor to Quantify Localized ERK Activation in Living Cells
- (2013) Lutz Kummer et al. CHEMISTRY & BIOLOGY
- Location Matters: Site of Conjugation Modulates Stability and Pharmacokinetics of Antibody Drug Conjugates
- (2013) Pavel Strop et al. CHEMISTRY & BIOLOGY
- Elotuzumab and daratumumab: emerging new monoclonal antibodies for multiple myeloma
- (2013) Junya Kuroda et al. Expert Review of Anticancer Therapy
- Structural and Pharmacological Characterization of Novel Potent and Selective Monoclonal Antibody Antagonists of Glucose-dependent Insulinotropic Polypeptide Receptor
- (2013) Peter Ravn et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Engineered Protease-resistant Antibodies with Selectable Cell-killing Functions
- (2013) Michelle Kinder et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Antibodies to watch in 2014
- (2013) Janice M Reichert mAbs
- Approval of the first biosimilar antibodies in Europe
- (2013) Alain Beck et al. mAbs
- CDR-restricted engineering of native human scFvs creates highly stable and soluble bifunctional antibodies for subcutaneous delivery
- (2013) Brian J Fennell et al. mAbs
- Rapid Fc glycosylation analysis of Fc fusions with IdeS and liquid chromatography mass spectrometry
- (2013) Heather Lynaugh et al. mAbs
- Rapid and multi-level characterization of trastuzumab using sheathless capillary electrophoresis-tandem mass spectrometry
- (2013) Rabah Gahoual et al. mAbs
- The structure of dual-variable-domain immunoglobulin molecules alone and bound to antigen
- (2013) Ivan Correia et al. mAbs
- Developability studies before initiation of process development
- (2013) Xiaoyu Yang et al. mAbs
- Production of stable bispecific IgG1 by controlled Fab-arm exchange
- (2013) Michael J Gramer et al. mAbs
- Monoclonal antibody therapeutics with up to five specificities: Functional enhancement through fusion of target-specific peptides
- (2013) David LaFleur et al. mAbs
- Site-specific antibody drug conjugates for cancer therapy
- (2013) Siler Panowski et al. mAbs
- Structure reveals function of the dual variable domain immunoglobulin (DVD-Ig™) molecule
- (2013) Clarissa G. Jakob et al. mAbs
- Correct primary structure assessment and extensive glyco-profiling of cetuximab by a combination of intact, middle-up, middle-down and bottom-up ESI and MALDI mass spectrometry techniques
- (2013) Daniel Ayoub et al. mAbs
- Methods for site-specific drug conjugation to antibodies
- (2013) Christopher R Behrens et al. mAbs
- Antibody-drug conjugate model fast characterization by LC-MS following IdeS proteolytic digestion
- (2013) Elsa Wagner-Rousset et al. mAbs
- Combining phenotypic and proteomic approaches to identify membrane targets in a ‘triple negative’ breast cancer cell type
- (2013) Steven Rust et al. Molecular Cancer
- MM-141, an IGF-IR- and ErbB3-Directed Bispecific Antibody, Overcomes Network Adaptations That Limit Activity of IGF-IR Inhibitors
- (2013) J. B. Fitzgerald et al. MOLECULAR CANCER THERAPEUTICS
- Development of a generic adenovirus delivery system based on structure-guided design of bispecific trimeric DARPin adapters
- (2013) B. Dreier et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structural Basis for Eliciting a Cytotoxic Effect in HER2-Overexpressing Cancer Cells via Binding to the Extracellular Domain of HER2
- (2013) Christian Jost et al. STRUCTURE
- Function-first antibody discovery
- (2013) Björn Frendéus OncoImmunology
- Characterization of Therapeutic Antibodies and Related Products
- (2012) Alain Beck et al. ANALYTICAL CHEMISTRY
- Biosimilar, Biobetter, and Next Generation Antibody Characterization by Mass Spectrometry
- (2012) Alain Beck et al. ANALYTICAL CHEMISTRY
- The role of B7 family molecules in hematologic malignancy
- (2012) P. Greaves et al. BLOOD
- Radiotherapy Increases the Permissiveness of Established Mammary Tumors to Rejection by Immunomodulatory Antibodies
- (2012) I. Verbrugge et al. CANCER RESEARCH
- Development of an Fc-Enhanced Anti-B7-H3 Monoclonal Antibody with Potent Antitumor Activity
- (2012) D. Loo et al. CLINICAL CANCER RESEARCH
- A novel role for junctional adhesion molecule-A in tumor proliferation: Modulation by an anti-JAM-A monoclonal antibody
- (2012) Liliane Goetsch et al. INTERNATIONAL JOURNAL OF CANCER
- Identification of broadly protective human antibodies toPseudomonas aeruginosaexopolysaccharide Psl by phenotypic screening
- (2012) Antonio DiGiandomenico et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Progress in overcoming the chain association issue in bispecific heterodimeric IgG antibodies
- (2012) Christian Klein et al. mAbs
- Antitumor Activity of a Novel Bispecific Antibody That Targets the ErbB2/ErbB3 Oncogenic Unit and Inhibits Heregulin-Induced Activation of ErbB3
- (2012) C. F. McDonagh et al. MOLECULAR CANCER THERAPEUTICS
- Tanibirumab (TTAC-0001): A fully human monoclonal antibody targets vascular endothelial growth factor receptor 2 (VEGFR-2)
- (2011) Sang Hoon Lee ARCHIVES OF PHARMACAL RESEARCH
- Developability Index: A Rapid In Silico Tool for the Screening of Antibody Aggregation Propensity
- (2011) Timothy M. Lauer et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Glycoengineered Pichia produced anti-HER2 is comparable to trastuzumab in preclinical study
- (2011) Ningyan Zhang et al. mAbs
- Therapeutic Fc-fusion proteins and peptides as successful alternatives to antibodies
- (2011) Alain Beck et al. mAbs
- Acceptable changes in quality attributes of glycosylated biopharmaceuticals
- (2011) Martin Schiestl et al. NATURE BIOTECHNOLOGY
- Biosimilars—why terminology matters
- (2011) Martina Weise et al. NATURE BIOTECHNOLOGY
- European Medicines Agency workshop on biosimilar monoclonal antibodies
- (2010) Janice M. Reichert et al. mAbs
- GlycoFi's technology to control the glycosylation of recombinant therapeutic proteins
- (2009) Alain Beck et al. Expert Opinion on Drug Discovery
- Tumor-associated and microbial proteases compromise host IgG effector functions by a single cleavage proximal to the hinge
- (2009) R. J. Brezski et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Toward biosimilar monoclonal antibodies
- (2008) Christian K Schneider et al. NATURE BIOTECHNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More